Hepatitis E vaccine HEV 239 significantly reduces the risk of symptomatic hepatitis E among individuals with chronic ...
Hepatitis B virus (HBV) infection remains an urgent global health concern, affecting hundreds of millions of people and significantly heightening the risk ...
Hepatitis B virus (HBV) is the leading cause of cirrhosis, hepatocellular carcinoma, and liver-related death globally.1,2 The highest prevalence is found in low-income and middle-income countries ...
SAN FRANCISCO, CA, USA I March 13, 2025 I Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first patient in its Phase 3 ECLIPSE ...
Tes HBsAG adalah salah satu skrining prenatal yang perlu dilakukan ibu hamil. Apa artinya jika HBsAG positif pada ibu hamil?
The following is a summary of "Impact of HBsAg reduction via siRNA treatment on natural and vaccine (BRII-179)-induced ...
Effectiveness of the hepatitis E vaccine HEV 239 amongst high-risk groups isn’t well studied. Here, Zhuang et al. analyse a decade of surveillance data (2007–2017) from Dongtai, China ...
The American Gastroenterological Association (AGA) has released an updated clinical practice guideline on the prevention of ...
Epitopea has inked a license and research collaboration with Merck to discover new tumor-specific antigens from so-called “dark matter” DNA, which are parts of ...
As for efficacy, the company said that two out of three trial subjects witnessed a “substantial” decline in Hepatitis B surface antigen after the first dosing administration. The company ...
The 7 major Chimeric Antigen Receptor (CAR) T-Cell Therapy markets reached ... of 5.71% during 2024-2034. Viral Hepatitis Market: The 7 major viral hepatitis markets are expected to exhibit a CAGR of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback